Equinox (Decision/Risk Analysis) Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $14M
Latest Deal Amount
  • Investors
  • 4

Equinox (Decision/Risk Analysis) General Information

Description

Developer of glaucoma treatment technology intended to treat diseases of the optic nerve. The company's technology uses adjustable, non-surgical, a non-pharmacological system which utilizes the natural laws of physics to balance pressures in and around their eye, enabling doctors to understand glaucoma based on deep exploration into the physics of the eye pressure.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Primary Office
  • 2424 South East Bristol Street
  • Suite 250
  • Newport Beach, CA 92660
  • United States
+1 (949) 000-0000

Equinox (Decision/Risk Analysis) Timeline

2017201820192020
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Equinox (Decision/Risk Analysis) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 05-Sep-2019 $14M 0000 Completed Generating Revenue
4. Early Stage VC (Series B) 03-Mar-2018 0000 0000 Completed Generating Revenue
3. Angel (individual) 19-Dec-2017 00.000 Completed Generating Revenue
2. Grant 01-Mar-2015 Completed Generating Revenue
1. Angel (individual) Completed Startup
To view Equinox (Decision/Risk Analysis)’s complete valuation and funding history, request access »

Equinox (Decision/Risk Analysis) Executive Team (6)

Name Title Board Seat Contact Info
John Berdahl MD Founder, Board Member & Chief Executive Officer
Matthew Larson Chief Operating Officer & President
Vanessa Tasso Vice President & Principal
Gary Berman Chief Business Officer
George Tsai Vice President, Research & Development and Operations
You’re viewing 5 of 6 executive team members. Get the full list »

Equinox (Decision/Risk Analysis) Board Members (8)

Name Representing Role Since
J. Corley Self Board Member 000 0000
Jeffry Weinhuff Visionary Venture Fund Board Member 000 0000
John Berdahl MD Equinox (Decision/Risk Analysis) Founder, Board Member & Chief Executive Officer 000 0000
Richard Lindstrom MD Self Board Member 000 0000
Stuart Raetzman Equinox (Decision/Risk Analysis) Executive Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Equinox (Decision/Risk Analysis) Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Flying L Partners Venture Capital Minority 000 0000 000000 0
Visionary Venture Fund Venture Capital Minority 000 0000 000000 0
Bluestem Capital Company PE/Buyout Minority 000 0000 000000 0
National Space Biology Research Institute Corporation 000 0000 000000 0
To view Equinox (Decision/Risk Analysis)’s complete investors history, request access »